Evaluating the Efficacy of the Flush Advanced+ Dietary Supplement Drink Mix Compared to a Placebo in Women Ages 18-75 With a History of Recurrent, Bothersome Urinary Tract Symptoms
Public ClinicalTrials.gov record NCT07856550. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of the Flush Advanced+ Dietary Supplement Drink Mix to Improve Urinary Health Measures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to evaluate the efficacy of the Flush Advanced+ dietary drink mix to reduce bothersome urinary tract symptoms compared to a placebo. The main questions it aims to answer are: * Does the Flush Advanced+ dietary drink mix reduce the number of episodes bothersome urinary tract symptoms over the course of six months compared to a placebo? * Does the Flush Advanced+ dietary drink mix reduce the severity of bothersome urinary tract symptoms? Researchers will compare the Flush Advanced+ dietary drink mix to a placebo (a look-alike substance that contains no active ingredients) to determine if the Flush Advanced+ dietary drink mix reduces the frequency and severity of bothersome urinary tract symptoms. Participants will: * Take the Flush Advanced+ dietary drink mix or a placebo every day for approximately 6 months * Complete electronic daily diaries to capture any acute episodes of bothersome urinary tract symptoms * Complete electronic questionnaires every other week to capture any bothersome urinary tract symptoms and urinary health-related quality of life measures * Complete check-in phone calls with a research team member every other month
Study identification
- NCT ID
- NCT07856550
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- Flush Advanced+ Dietary Drink Mix Dietary Supplement
- Placebo Dietary Drink Mix Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 16, 2026 (Actual)
- Primary completion
- Feb 2027 (Estimated)
- Completion
- Feb 2027 (Estimated)
- Last update posted
- Oct 2, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bonafide Health | Harrison | New York | 10528 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07856550, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2026 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07856550 live on ClinicalTrials.gov.